Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Randomized Controlled Trial of ChondroCelect® (Via Autologous Chondrocyte Implantation) vs Microfracture (as Procedure) in the Repair of Symptomatic Cartilaginous Defects of the Femoral Condyles

NCT00414700 is registered in ClinicalTrials.gov with TiGenix n.v. as lead sponsor.

NCT NCT00414700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00414700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Randomized Controlled Trial of ChondroCelect® (Via Autologous Chondrocyte Implantation) vs Microfracture (as Procedure) in the Repair of Symptomatic Cartilaginous Defects of the Femoral Condyles
Lead sponsor
TiGenix n.v.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2002
Completion date
January 31, 2010
Enrollment
118 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage lesion of the femoral condyle